 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Affy Says Genotyping Arrays a Bright Spot amid Q1 Revenue Drop; Plans to Close eBioscience Buy in Q2
May 08, 2012
Affy Says Genotyping Arrays a Bright Spot amid Q1 Revenue Drop; Plans to Close eBioscience Buy in Q2
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Arrays Increasingly Adopted for Stillbirth Studies, though Questions about Cost, Counseling Remain
June 18, 2013 / BioArray News - BlueGnome, Expanding Cyto Menu, Debuts High-Resolution, 850K SNP Chip on Illumina Platform
June 18, 2013 / BioArray News - IP Roundup: Asuragen, NuGen Technologies, Alere, Affymetrix, University of Colorado
June 18, 2013 / BioArray News - Q&A: Baylor's Marilyn Li on the Clinical Application of Microarrays and Sequencing in Cancer
June 11, 2013 / BioArray News - Pan-Asian Population Genomics Initiative to Embark on Multiple GWAS to ID Variants of Interest
May 28, 2013 / BioArray News